crohn's disease and semaglutide GLP-1s Disease: Safety, Biomarkers, and Provider G... – PlexusDx Crohn's Disease Treatment - ColoWell

It simultaneously activates: GLP-1 appetite & cravings control GIP metabolic regulation Glucagon increases calorie burning & fat mobilization This three-lane approach makes Retatrutide fundamentally different from other medications, potentially placing it closer to bariatric-surgery outcomes but without surgery

for others the combination is selected from the outset

Its the use of food to regulate emotionsstress, anxiety, loneliness, boredom, grief, or overwhelmrather than physical hunger

There are also at least two ongoing lawsuits in Tennessee involving GLP-1s

Most patients with mild illness continue treatment without issue, but individual responses vary, and your provider needs updated clinical information to guide safe, personalized recommendations